K&F Growth Acquisition II
KFIIR · NASDAQ
About KFIIR
- Employees
- 0
- Headquarters
- Manhattan Beach, California
- Listed
- Feb 5, 2025
- Sector
- N/A
- Industry
- N/A
KFIIR key statistics
- Market cap
- 420.43M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 207.38K
- Volume
- 31.20K
- Open price
- $0.11
- High today
- $0.11
- Low today
- $0.1003
- 52 Week high
- $0.22
- 52 Week low
- $0.051
K&F Growth Acquisition II (KFIIR) at a glance
K&F Growth Acquisition II (KFIIR) last traded at $0.105, with a market cap of 420.43M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.1003 and $0.11. The current price is 4.7% above the day's low and 4.5% below its high.
Volume so far is 31.20K shares, below the average of 207.38K shares a day.
Over the past year K&F Growth Acquisition II has ranged from $0.051 to $0.22, and now sits 32% of the way up that range.
KFIIR news
- Press releaseBusiness Wire
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.